Biopharmaceutical Section of the American Statistical Association

Overview

The Biopharmaceutical Section (BIOP) is a special interest section for the application of statistics to the development and use of therapeutic drugs and devices in humans and animals. 

The primary interests of the Section are 

  • the biochemical and physical sciences involved with drug, biologics, and device discovery, formulations, product development, and quality control;
  • the biological sciences involved in evaluating drug and device safety and efficacy of therapeutic drugs, biologics, and devices;
  • experimental human and veterinary medicine in support of therapeutic drugs, biologics, and devices;
  • health promotion and disease prevention and intervention activities; and 
  • product toxicity and disease surveillance. 



Announcements

STATBOLIC is a platform to advance statistical innovation, foster collaboration among statisticians and scientists across industry, regulatory, academia, and policy sectors, and enable the efficient development of treatments for metabolic disorders. Check out the conference webpage for more information: https://community.amstat.org/statbolic/home 

  The ASA BIOP Distance Learning Committee presents the first webinar of 2026 featuring a presentation by the winners of the 2025 Stan Altan Best Paper Award! Register today: https://www.ticketleap.events/tickets/asabiop/asa-biop-distance-learning-webinar-series-february

Check out the 2025 Winter Issue of the Biopharmaceutical Report: 2025 Winter Issue - ASA Biopharmaceutical Report

Latest Discussions

There are no discussions to which you have access

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Recent Shared Files

No Data Found

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Need to contact us?  biopharmaceutical@amstat.org